Hikal - Quaterly Results

10 Aug 2022 Evaluate
A decrease in the sales to Rs. 3787.90 millions was observed for the quarter ended June 2022. The sales stood at Rs. 4567.80 millions during the similar quarter previous year.The Net Loss for the quarter ended June 2022 is Rs. -89.40 millions as compared to Net Profit of Rs. 505.00 millions of corresponding quarter ended June 2021A decline of 259.40 millions was observed in the OP in the quarter ended June 2022 from 989.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 3787.90 4567.80 -17.07 3787.90 4567.80 -17.07 19427.20 17204.40 12.92
Other Income 32.70 31.80 2.83 32.70 31.80 2.83 48.90 49.80 -1.81
PBIDT 259.40 989.00 -73.77 259.40 989.00 -73.77 3454.50 3278.70 5.36
Interest 112.90 79.90 41.30 112.90 79.90 41.30 312.10 362.00 -13.78
PBDT 146.50 909.10 -83.89 146.50 909.10 -83.89 3142.40 2916.70 7.74
Depreciation 265.00 225.60 17.46 265.00 225.60 17.46 956.70 852.40 12.24
PBT -118.50 683.50 -117.34 -118.50 683.50 -117.34 2185.70 2064.30 5.88
TAX -29.10 178.50 -116.30 -29.10 178.50 -116.30 580.60 732.80 -20.77
Deferred Tax -29.10 -10.40 179.81 -29.10 -10.40 179.81 -15.90 -62.70 -74.64
PAT -89.40 505.00 -117.70 -89.40 505.00 -117.70 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 6.85 21.65 -68.37 6.85 21.65 -68.37 17.78 19.06 -6.69

Hikal Share Price

390.75 3.10 (0.80%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.